By: Rishika Sadam
By Rishika Sadam HYDERABAD, April 16 (Reuters) - Hetero Labs, one of India's largest privately held drugmakers, aims to sell 1.5 million
Rishika Sadam is a Senior Correspondent at various esteemed outlets, including Yahoo Finance and ThePrint. She specializes in the fields of medicine and healthcare, focusing on pharmaceutical manufacturing, regulation, and health-related topics such as consumer health and wellness programs. Rishika's work has been featured in numerous publications, including Reuters, The Globe and Mail, and Yahoo News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
India (National)


Not enough data
Rishika Sadam's coverage heavily revolves around politics, government announcements, and breaking news in India, particularly focusing on Telangana and Hyderabad. She has covered diverse topics including business, pharmaceuticals, space race, train collision among others.
Given her focus on political themes and government announcements at a national level with specific attention to Telangana and Hyderabad, she is likely most interested in pitches that offer unique angles or local perspectives related to these areas. For instance, expert commentary on the impact of government decisions or political events within India could be well-received by Rishika.
Additionally, as she covers a wide range of topics such as business and pharmaceuticals alongside politics-related content., relevant insights into these industries may also capture her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .